A B S T R A C T To define the role of verapamil in the treatment of ventricular tachycardia (VT), we studied 21 patients with chronic recurrent VT. Electrophysiologic studies were performed before and during intravenous infusion of verapamil (0.15 mg/kg followed by 0.005 mg/kg per min). On the basis of the mode of VT initiation and termination, we identified three groups of patients: (a) 11 patients had VT suggestive of reentry, as VT could be initiated with ventricular extrastimulation and terminated with overdrive ventricular pacing. Verapamil did not affect the inducibility and cycle length of VT. (b) 7 patients had VT suggestive of catecholamine-sensitive automaticity as VT could not be initiated with programmed electrical stimulation but could be provoked by isoproterenol infusion. Moreover, the VT could not be converted to a sustained sinus rhythm with overdrive ventricular pacing and it resolved only with discontinuing isoproterenol infusion. Verapamil exerted no effects on VT. (c) 3 patients had VT with electrophysiologic characteristics suggestive of triggered activity related to delayed afterdepolarizations. Characteristically, after attaining a range of cycle lengths, the sinus, atrial or ventricular paced rhythm could initiate VT without ventricular extrastimulation. The first beat of VT invariably occurred late in the cardiac cycle with a premature coupling interval 0-80 ms shorter than the preceding QRS cycle length; the premature coupling interval gradually decreased as the sinus, atrial or ventricular paced cycle length progressively shortened. Of
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We studied 21 patients whose ventricular tachycardia could be reproduced in our cardiac electrophysiology laboratory. Effects of verapamil on ventricular tachycardia were analyzed according to the mode of arrhythmia initiation and termination. Our findings suggest that among the various mechanisms of cardiac arrhythmias: reentry, automaticity, and triggered activity (13) (14) (15) , verapamil is only effective in suppressing ventricular tachycardia with electrophysiologic characteristics consistent with triggered activity related to delayed afterdepolarizations. Table I . Nine patients had arteriosclerotic Incremental pacing. The high right atrium or right venheart disease with myocardial infarction of >6 mo before tricle was paced for 5-10 beats with abrupt cessation. We the study, five patients had cardiomyopathy, and the re-began pacing with a cycle length slightly shorter than that maining seven patients had no clinical evidence of organic of the sinus rhythm. After each burst of pacing we decreased heart disease except for the rhythm disturbance. the pacing cycle length by 10-20 ms. The shortest pacing Electrophysiology study. All patients gave informed con-cycle length was 250 ms. sent, and all antiarrhythmic drugs were discontinued for at Extrastimulation. Following incremental pacing, the high least over five half-lives before the study. The study was right atrium or right ventricle was driven at one or more performed with patients in a postabsorptive, nonsedated cycle lengths (SI-SI) (usually 600 and 400 ms), and an atrial state. With the conventional method (16) , a quadripolar or ventricular premature beat (S2) was introduced from late electrode catheter was introduced from the right femoral diastole at progressively shorter coupling intervals (S1-S2) vein (17) .
METHODS
Intravenous administration of verapamil. Following termination of ventricular tachycardia, intravenous verapamil was administered during sinus rhythm (0.15 mg/kg infused over 2 min as the loading dose followed by continuous infusion at 0.005 mg/kg per min). During verapamil infusion, programmed electrical stimulation protocol was repeated or intravenous infusion of isoproterenol was reinstituted to assess effects of verapamil. Serial blood samples were drawn for measurements of plasma verapamil concentration (18) immediately, 5 min, 15 min, and 30 min after the loading injection. The plasma verapamil concentrations peaked at the end of the loading phase ranging from 132 to 286 (mean, 161±35) ng/ml, then leveled off during the continuous infusion phase with a mean concentration of 126±22 ng/ml.
Classification of mechanisms of ventricular tachycardia. Mechanisms of ventricular tachycardia can only be presumptive during electrophysiologic studies in humans (19, 20) . The following electrophysiologic principles (13) (14) (15) were applied.
Reentry (Fig. 1, A and B) . In these four patients, the tachycardia could be readily terminated by overdrive ventricular pacing (Fig. 2) . Of note, there was progressive lengthening of the interval between the initiating ventricular premature beat (S2) and the first beat of tachycardia in response to increasing prematurity of ventricular extrastimulation (Fig. 1, A (Fig. 3) . In contrast to reentrant ventricular tachycardia, ventricular tachycardia so induced could not be converted to a sustained sinus rhythm with overdrive ventricular pacing. One example is illustrated in Fig. 4 . In each instance, ventricular tachycardia resolved after discontinuation of isoproterenol infusion. During intravenous infusion of verapamil, institution of isoproterenol infusion at the same dosage of [2] [3] [4] ,g/min invariably provoked the same form of ventricular tachycardia at the same rate in all seven patients. Verapamil thus appeared to exert no antiarrhythmic effects in this group of patients. Ventricular tachycardia with electrophysiologic characteristics consistent with triggered activity related to delayed afterdepolarizations. In the remaining three patients (cases 6, 10, and 21), the mode of initiation of ventricular tachycardia was distinctly different from those described above. In each patient the tachycardia could be initiated by accelerating the sinus rate, however, if the sinus rate was accelerated beyond a critical range, the tachycardia could no longer be initiated (Fig. 5, A-D) . This phenomenon could be reproducibly demonstrated either with hyperventilation or with handgrip. The critical range of sinus cycle lengths that initiated ventricular tachycardia varied slightly each day and it measured 520-720, 490-530, and 450-710 ms, respectively, for the three patients (cases 6, 10, and 21). Furthermore, the first beat of ventricular tachycardia usually occurred late in the cardiac cycle: 0-80 ms shorter than the preceding sinus cycle length. During verapamil infusion, repeated hyperventilation and handgrip could no longer initiate the arrhythmia despite acceleration of the sinus rate with cycle lengths to be within the critical range in all three patients (Fig. 5, E and F) . None of these three patients were taking digitalis, and these findings were not observed in either group I or group II patients. During electrophysiologic studies, atrial or ventricular extrastimulation did not elicit ventricular tachycardia. However, incremental atrial or ventricular pacing for [5] [6] [7] [8] [9] [10] beats within the similar range of cycle lengths reproducibly initiated ventricular tachycardia (Figs. 6 and 7) . The interval between the first beat of ventricular tachycardia and the last paced beat (QRS complex) was also noted to gradually decrease as the paced cycle length (R-R interval) progressively shortened (Figs. 6, 7, and 8 During intravenous verapamil infusion, early development of atrioventricular nodal block precluded attainment of the critical range of cycle lengths (R-R interval) with atrial pacing. Thus, the effects of verapamil on the initiation of ventricular tachycardia during atrial pacing could not be assessed. Nevertheless, ventricular pacing within the critical range of cycle lengths could no longer initiate the arrhythmia in all three patients (Fig. 9) .
DISCUSSION
The results of this study indicate that intravenous verapamil at concentrations of 126±22 ng/ml does not exert antiarrhythmic effects on ventricular tachyeardia with a mode of initiation and termination suggestive of either reentry or catecholamine-sensitive automaticity as the underlying mechanism. However, verapamil at these concentrations is effective in suppressing ventricular tachycardia with electrophysiologic characteristics consistent with triggered activity related to delayed afterdepolarizations (13) (14) (15) 20) . ,,Suu G St _0 ,____ _... FIGURE 4 Response of isoproterenol-induced ventricular tachycardia to overdrive ventricular pacing (same patient as in Fig. 3 ). The ventricular tachycardia has a cycle length of 325 ms as shown in Fig. 3 Ventricular tachycardia due to triggered activity related to delayed afterdepolarizations. Triggered activity related to delayed afterdepolarizations has been identified and characterized in both isolated animal and human tissues (21) (22) (23) (24) (25) (26) (27) (28) (29) . It has been observed in the presence as well as the absence of digitalis intoxication. However, the mechanism by which delayed afterdepolarizations occur is still incompletely understood. Experimental studies have led other investigators to suggest that these afterdepolarizations occur after a transient current carried by sodium and modulated by calcium (30) (31) (32) . By inhibiting the calciumdependent slow channel response (33) (34) (35) , verapamil may suppress these delayed afterdepolarizations (25) (26) (27) (28) (29) . In keeping with these findings, we suggest that verapamil may prevent initiation of ventricular tachycardia with electrophysiologic characteristics consistent with triggered activity related to delayed afterdepolarizations in man. Of note was the observation that all three patients who had ventricular tachycardia suggestive of triggered activity had no clinical evidence of organic heart disease.
Ventricular tachycardia suggestive of triggered activity (group III patients) conforms to some of the electrophysiologic features described in isolated tissue preparations (15, (21) (22) (23) (24) (25) (26) (27) (28) (29) . However, we realize that differentiation between reentry and triggered activity remains difficult. This is because both reentry and triggered activity may have similar clinical electrophysiologic manifestations despite having differences in their basic electrophysiologic mechanisms.
(a) Delayed afterdepolarizations do not occur spontaneously. Their occurrence depends on previous depolarizations (15) . Similar to reentry, triggered activity can, therefore, be initiated by programmed electrical stimulation. It may be initiated by both atrial and ventricular pacing as demonstrated in the present study. In contrast, a reentrant ventricular tachycardia is rarely initiated from the atrium (36, 37) .
(b) The amplitude of delayed afterdepolarizations increases as the basic driving cycle length shortens (15) . The initiation of an onset of triggered activity is thus a cycle length-dependent phenomenon. Nevertheless, shortening of the basic driving cycle length may induce unidirectional block in one pathway and slow conduction in the other pathway, setting up conditions for reentry to occur (13, 15, 20 suggested that the slow channel action potentials may become dominant under pathologic conditions, such as myocardial ischemia, in regions of the heart ordinarily dominated by the fast sodium channel response (39, 40) . Such slow channel action potentials have been implicated in the genesis of reentrant ventricular arrhythmias because of their propensity for very slow propagation of impulses (41, 42) . In chronic infarcted canine hearts with inducible reentrant ventricular arrhythmia, El-Sherif and Lazzara (43) noted that verapamil could suppress the arrhythmia, whereas Davis et al. (44) found that verapamil was totally ineffective. However, El-Sherif and Lazzara (43) Fig. 5 ). The interval between the first beat of ventricular tachycardia and its preceding atrial paced beat (QRS complex) is designated as VPCa (Fig. 6) and that between the first beat of ventricular tachycardia and its preceding ventricular paced beat (Fig. 7) is designated as VPCV.
Both VPC. and VPCv are plotted against the driving cycle length (CL; R-R interval). Note that the VPC, and VPC, intervals gradually shorten as the driving cycle length (CL) progressively decreases. fast sodium channel rather than the calcium-dependent slow channel response (45, 46) in our group I patients.
Ventricular tachycardia due to catecholamine-sensitive automaticity. It has also been postulated that the calcium-dependent slow channel response may become dominant, and, in turn, may give rise to an automatic rhythm under pathologic conditions (39, 40) . In this situation, verapamil would be expected to be effective in suppressing such an automatic rhythm. The negative finding of our study suggests that automatic ventricular tachycardia provocable with isoproterenol is probably not of a form of automatic rhythm caused by the calcium-dependent slow channel response. Unfortunately, because of the limitations of the study technique, we were not able to make dif- , and 500 (C) ms, respectively, initiates no ventricular tachycardia. Note that ventricular pacing at these cycle lengths initiates onset of ventricular tachycardia before verapamil infusion as shown in Fig. 7 (B, C, and D).
ferentiation between normal and abnormal automaticity (13) (14) (15) 
